Health Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patients

Published on 06/06/2025 at 07:01

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Roche Holding AG

Thermo Fisher acquires Sanofi's New Jersey manufacturing site	09:48am	RE
Thermo Fisher acquires Sanofi's New Jersey manufacturing site	09:45am	RE
OraSure Technologies received takeover bid from industry entrepreneur, sources say	Jul. 14	RE
ROCHE HOLDINGS AG : JP Morgan remains a Sell rating	Jul. 14	ZD
ROCHE HOLDINGS AG : Buy rating from UBS	Jul. 10	ZD
Swiss Market Index Closes Higher; SGS Shares Down	Jul. 09	MT
ROCHE HOLDINGS AG : JP Morgan reaffirms its Sell rating	Jul. 09	ZD
Deutsche Bank Remains Cautious on Pharmaceutical Sector Ahead of Earnings Season	Jul. 08	FW
ROCHE HOLDINGS AG : Deutsche Bank gives a Sell rating	Jul. 08	ZD
European shares fall as banks, mining stocks losses weigh	Jul. 04	RE
Swiss Market Index Closes Flat; Drugmakers Gain on US-Swiss Trade Deal Talks	Jul. 04	MT
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	Jul. 04	ZD
Roche's Lebanese Unit Renews Healthcare Collaboration with Universities	Jul. 03	MT
Berenberg Cuts Zealand Pharma's Price Target Amid Increased Competition	Jul. 01	MT
ROCHE HOLDINGS AG : UBS reaffirms its Buy rating	Jul. 01	ZD
Amgen says gastric cancer drug meets main goal in late-stage trial	Jun. 30	RE
Rakovina Therapeutics Inc. Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025	Jun. 30	CI
ROCHE HOLDINGS AG : Receives a Sell rating from JP Morgan	Jun. 30	ZD
Roche Head of Pharma Research and Early Development to Retire	Jun. 30	DJ
Bayer Receives EU Approval for Extended Eylea Treatment Intervals	Jun. 27	DP
Roche Diagnostics, Egypt's UPA Partner to Advance Green Procurement in Healthcare	Jun. 26	MT
Roche Holding AG - Special Call	Jun. 23
Lineage Cell Therapeutics, Inc. Announces 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025	Jun. 23	CI
Roche: positive Phase I/II data in hemophilia A	Jun. 23
Roche's Hemophilia Drug Shows Hemostatic Normalization Potential in Early-stage Study	Jun. 23	MT